#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance


article has not abstract


Vyšlo v časopise: A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance. PLoS Med 8(4): e32767. doi:10.1371/journal.pmed.1001022
Kategorie: Policy Forum
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001022

Souhrn

article has not abstract


Zdroje

1. BoucherHWTalbotGHBradleyJSEdwardsJEGilbertD

2009

Bad bugs, no drugs: no ESKAPE! An update from the Infectious

Diseases Society of America.

Clin Infect Dis

48

1

12

2. NugentRBackEBeithA

Center for Global Development Drug Resistance Working Group

2010

The race against drug resistance.

Washington (D.C.)

Center for Global Development

3. World Health Organization.

2008

International health regulations (2005).

Geneva

World Health Organization

4. NordmannPCuzonGNaasT

2009

The real threat of Klebsiella pneumoniae

carbapenemase-producing bacteria.

Lancet Infect Dis

9

228

236

5. VatopoulosA

2008

High rates of metallo-beta-lactamase-producing Klebsiella

pneumoniae in Greece—a review of the current

evidence.

Euro Surveill

13

8023

6. KumarasamyKKTolemanMAWalshTRBagariaJButtF

2010

Emergence of a new antibiotic resistance mechanism in India,

Pakistan, and the UK: a molecular, biological, and epidemiological

study.

Lancet Infect Dis

10

597

602

7. RolainJMParolaPCornagliaG

2010

New Delhi metallo-beta-lactamase (NDM-1): towards a new

pandemia?

Clin Microbiol Infect

12

1699

1701

8. SchwaberMJKlarfeld-LidjiSNavon-VeneziaSSchwartzDLeavittA

2008

Predictors of carbapenem-resistant Klebsiella

pneumoniae acquisition among hospitalized adults and effect of

acquisition on mortality.

Antimicrob Agents Chemother

52

1028

1033

9. PatelGHuprikarSFactorSHJenkinsSGCalfeeDP

2008

Outcomes of carbapenem-resistant Klebsiella

pneumoniae infection and the impact of antimicrobial and

adjunctive therapies.

Infect Control Hosp Epidemiol

29

1099

1106

10. US Food and Drug Administration

2010

FDA drug safety communication: increased risk of death with Tygacil

(tigecycline) compared to other antibiotics used to treat similar

infections. Available: http://www.fda.gov/Drugs/DrugSafety/ucm224370.htm. Accessed

14 March 2011

11. MoelleringRC

2010

NDM-1—a cause for worldwide concern.

New Eng J Med

363

2377

2379

12. SchwaberMJLevBIsraeliASolterESmollanG

2011

Containment of a country-wide outbreak of carbapenem-resistant

Klebsiella pneumoniae in Israeli hospitals via a

nationally-implemented intervention.

Clin Infect Dis

52

1

8

13. HausteinTHollmeyerHHardimanMHarbarthSPittetD

2011

Should this event be notified to WHO?

Reliability of the International Health Regulations notification

assessment process. Bull WHO

In press

14. WHO Global Task Force on XDR-TB

2007

Report of the meeting of the WHO Global Task Force on XDR-TB,

9-10 October 2006.

Geneva

World Health Organization

15. World Health Organization

2008

WHO guidance for the use of Annex 2 of the International Health

Regulations (2005).

Geneva

World Health Organization

16. CarmeliYAkovaMCornagliaGDaikosGLGarauJ

2010

Controlling the spread of carbapenemase-producing Gram-negatives:

therapeutic approach and infection control.

Clin Microbiol Infect

16

102

111

17. ReAct

2007

Antibiotic resistance - a call for global

leadership.

Available: http://soapimg.icecube.snowfall.se/stopresistance/ReAct_response.pdf.

Accessed 14 March 2011

18. LarssonM

2010

Discourse at the the World Health Assembly.

Available: http://www.regeringen.se/sb/d/12546/a/146073. Accessed 14

March 2011

19. BogaertsPMontesinosIRodriguez-VillalobosHBlaironLDeplanoA

2010

Emergence of clonally related Klebsiella

pneumoniae isolates of sequence type 258 producing KPC-2

carbapenemase in Belgium.

J Antimicrob Chemother

65

361

362

20. HammerumAMHansenFLesterCHJensenKTHansenDS

2010

Detection of the first two Klebsiella pneumoniae

isolates with sequence type 258 producing KPC-2 carbapenemase in

Denmark.

Int J Antimicrob Agents

35

610

612

21. OsterbladMKirveskariJKoskelaSTissariPVuorenojaK

2009

First isolations of KPC-2-carrying ST258 Klebsiella

pneumoniae strains in Finland, June and August

2009.

Euro Surveill

14

19349

22. NaasTCuzonGBabicsAFortineauNBoytchevI

2010

Endoscopy-associated transmission of carbapenem-resistant

Klebsiella pneumoniae producing KPC-2

{beta}-lactamase.

J Antimicrob Chemother

65

1305

1306

23. CuzonGNaasTDemachyMCNordmannP

2008

Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in

Klebsiella pneumoniae isolate from

Greece.

Antimicrob Agents Chemother

52

796

797

24. BarbierFRuppeEGiakkoupiPWildenbergLLucetJ

2010

Genesis of a KPC-producing Klebsiella pneumoniae

after in vivo transfer from an imported Greek strain.

Euro Surveill

15

19457

25. Kassis-ChikhaniNDecreDIchaiPSengelinCGenesteD

2010

Outbreak of Klebsiella pneumoniae producing

KPC-2 and SHV-12 in a French hospital.

J Antimicrob Chemother

65

1539

1540

26. WendtCSchuttSDalpkeAHKonradMMiethM

2010

First outbreak of Klebsiella pneumoniae

carbapenemase (KPC)-producing K. pneumoniae in

Germany.

Eur J Clin Microbiol Infect Dis

29

563

570

27. TothADamjanovaIPuskasEJanvariLFarkasM

2010

Emergence of a colistin-resistant KPC-2-producing

Klebsiella pneumoniae ST258 clone in

Hungary.

Eur J Clin Microbiol Infect Dis

29

765

769

28. SamuelsenONaseerUToftelandSSkutlabergDHOnkenA

2009

Emergence of clonally related Klebsiella

pneumoniae isolates of sequence type 258 producing

plasmid-mediated KPC carbapenemase in Norway and Sweden.

J Antimicrob Chemother

63

654

658

29. Tegmark WisellKHaeggmanSGezeliusLThompsonOGustafssonI

2007

Identification of Klebsiella pneumoniae

carbapenemase in Sweden.

Euro Surveill 12: E071220

071223

30. MeessenNWiersingaJvan der ZwaluwKvan AltenaR

2010

First outbreak of carbapenemase-producing Klebsiella

pneumoniae in a tuberculosis care facility in the Netherlands.

Abstract number: P1283. Proceedings of the 20th European Congress of

Clinical Microbiology and Infectious Diseases (ECCMID); 10 April–13

April, 2010; Vienna, Austria.

Available: http://registration.akm.ch/2010eccmid_einsicht.php?XNABSTRACT_ID=104079&XNSPRACHE_ID=2&XNKONGRESS_ID=114&XNMASKEN_ID=900.

Accessed 14 March 2011

31. Cohen StuartJWVoetsGVersteegDScharringaJTersmetteM

2010

The first carbapenemase-producing Klebsiella

pneumoniae strains in the Netherlands are associated with

international travel. Abstract number: P1284. Proceedings of the 20th

European Congress of Clinical Microbiology and Infectious Diseases (ECCMID);

10 April–13 April, 2010; Vienna, Austria.

Available: http://registration.akm.ch/2010eccmid_einsicht.php?XNABSTRACT_ID=103461&XNSPRACHE_ID=2&XNKONGRESS_ID=114&XNMASKEN_ID=900.

Accessed 14 March 2011

32. JohnsonRBeckerG

2010

US-Russia meat and poultry trade issues. Washington (D.C.):

Congressional Research Service for Congress.

Available: http://www.nationalaglawcenter.org/assets/crs/RS22948.pdf.

Accessed 14 March 2011

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2011 Číslo 4
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#